pubmed-article:2384007 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0020205 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0080188 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0025417 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0443146 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0678579 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C0028423 | lld:lifeskim |
pubmed-article:2384007 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
pubmed-article:2384007 | pubmed:dateCreated | 1990-9-18 | lld:pubmed |
pubmed-article:2384007 | pubmed:abstractText | Experimental autoimmune uveoretinitis (EAU), induced in (LEW X BN) F1 rats by immunization with S antigen (S-Ag) is T cell and antibody (ab) mediated and anti-S-Ag IgE ab have been involved in the occurrence of ocular lesions. (LEW X BN) F1 rats repeatedly injected with HgCl2 develop an autoimmune disease characterized by numerous auto-ab and a high increase of serum IgE level. We hypothesize that large amounts of non anti-S-Ag IgE induced by HgCl2 would compete with anti-S-Ag induced by S-Ag immunization so as to prevent EAU to occur. Indeed (LEW X BN) F1 rats immunized with S-Ag 7 days after the first HgCl2 injection are strongly protected against EAU. The putative role of the different mercury-induced autoimmune phenomena in the protection against EAU are discussed. | lld:pubmed |
pubmed-article:2384007 | pubmed:language | eng | lld:pubmed |
pubmed-article:2384007 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2384007 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2384007 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2384007 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2384007 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2384007 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2384007 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2384007 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2384007 | pubmed:issn | 0271-3683 | lld:pubmed |
pubmed-article:2384007 | pubmed:author | pubmed-author:de KozakYY | lld:pubmed |
pubmed-article:2384007 | pubmed:author | pubmed-author:DruetPP | lld:pubmed |
pubmed-article:2384007 | pubmed:author | pubmed-author:YARDA SAS | lld:pubmed |
pubmed-article:2384007 | pubmed:author | pubmed-author:BellonBB | lld:pubmed |
pubmed-article:2384007 | pubmed:author | pubmed-author:ThillayeBB | lld:pubmed |
pubmed-article:2384007 | pubmed:author | pubmed-author:SaoudiAA | lld:pubmed |
pubmed-article:2384007 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2384007 | pubmed:volume | 9 Suppl | lld:pubmed |
pubmed-article:2384007 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2384007 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2384007 | pubmed:pagination | 135-8 | lld:pubmed |
pubmed-article:2384007 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:meshHeading | pubmed-meshheading:2384007-... | lld:pubmed |
pubmed-article:2384007 | pubmed:year | 1990 | lld:pubmed |
pubmed-article:2384007 | pubmed:articleTitle | Inhibition of experimental autoimmune uveoretinitis by mercuric chloride injections in (Lewis x Brown Norway) F1 hybrid rats. | lld:pubmed |
pubmed-article:2384007 | pubmed:affiliation | Pathologie Rénale et Vasculaire, INSERM U28, Hôpital Broussais, Paris, France. | lld:pubmed |
pubmed-article:2384007 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2384007 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |